| 发明名称 |
METHOD OF DETERMINING PANCREATIC DISEASE |
| 摘要 |
A method of determining pancreatic disease of the present invention is a method of determining whether an IPMN patient has pancreatic disease, the method including: a first step of measuring a concentration of S100P in duodenal juice of the IPMN patient; and a second step of determining the IPMN patient is a malignant IPMN patient or a pancreatic cancer patient when the concentration of the S100P is equal to or greater than a predetermined cutoff value, and the IPMN patient is a benign IPMN patient when the concentration of the S100P is smaller than the predetermined cutoff value. |
| 申请公布号 |
US2017122957(A1) |
申请公布日期 |
2017.05.04 |
| 申请号 |
US201715404861 |
申请日期 |
2017.01.12 |
| 申请人 |
OLYMPUS CORPORATION |
发明人 |
SANUKI Hiromi;NAKATA Mari;TAKEYAMA Tetsuhide |
| 分类号 |
G01N33/68 |
主分类号 |
G01N33/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of determining pancreatic disease that is a method of determining whether an IPMN patient has pancreatic disease, the method comprising:
a first step of measuring a concentration of S100P in duodenal juice of the IPMN patient; and a second step of determining the IPMN patient is a malignant IPMN patient or a pancreatic cancer patient when the concentration of the S100P is equal to or greater than a predetermined cutoff value, and the IPMN patient is a benign IPMN patient when the concentration of the S100P is smaller than the predetermined cutoff value. |
| 地址 |
Tokyo JP |
